Glucagon-like peptide-1 receptor agonists related to adolescent weight loss, study suggests

Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a new report.

Read more...